key: cord-0883575-yduki6vg
authors: De Biasio, Fabiola; Aratari, Annalisa; Festa, Stefano; Lorenzetti, Roberto; Papi, Claudio
title: No impact of restructuring IBD-related activity during COVID-19 outbreak on patient outcomes. A single Center experience
date: 2021-06-07
journal: Dig Liver Dis
DOI: 10.1016/j.dld.2021.05.037
sha: c5b8d8228d2434c58439321a1029f9eca2aaf74b
doc_id: 883575
cord_uid: yduki6vg

nan

The widespread diffusion of the coronavirus disease 2019 (COVID-19) has been one of the most dramatic challenges for health-care systems worldwide. Because of the huge number of symptomatic patients requiring hospitalization and intensive care treatment for severe COVID-19, most hospitals had to reset their priorities and to adapt their clinical activities to the management of patients affected by COVID-19. Several units have been reconverted into COVID-19 facilities, requiring the recruitment of medical and nursing staff taken from both medical and surgical departments; this rapid reorganization of service provision has led to a significant impact on daily health care for patients affected by other medical conditions, particularly patients with chronic diseases requiring long-term regular use of health-care resources.

In Italy, a substantial change of practice has been recorded in most Gastroenterology Units through the entire country: although urgent and emergent services have been generally guaranteed, outpatient consultations, endoscopic and ultrasound procedures have been significantly reduced and limited to urgencies and oncologic indications (1) . The restructuring of clinical activities also affected inflammatory bowel disease (IBD) units, most of them temporarily stopped and postponed non-urgent activities and implemented virtual follow-up clinics (telemedicine, phone calls and/or Email consultation) in order to reduce the risk of viral transmission while maintaining the minimum standard of IBD care (2) .

Little is known about the potential impact of these restructuring activities on IBDrelated outcomes such as risk of flare, complications, hospitalization or surgery. Emerging data suggest a potential collateral damage caused by the COVID-19 pandemic because of a decline in seeking medical attention and/or hospital admissions from several other conditions. A reduced rate of hospital admissions for acute coronary syndrome during Covid-19 outbreak has been reported in northern Italy as well as in the United States (3, 4) and an inflation in acute cardiovascular deaths, not related to COVID-19 infection, has been reported, probably because patients were not promptly referred to hospital during the pandemic (5). Moreover, a reduction in the number of patients diagnosed with various gastro-intestinal cancers has been reported as a consequence of the substantial drop in endoscopy services (6, 7) ; an increase in cancer deaths because of delay in diagnosis and screening procedures is expected in the near future (8, 9) . In summary, in our experience, restructuring clinical activities during lockdown had no significant impact on IBD clinical outcomes in the post lockdown phase. Some considerations can help to explain our results. The first one is how we have reset our priorities without reducing the level of care below acceptable standards for IBD patients. According to our Regional Health AuthoritY, during the lockdown period, in order to reduce the risk of transmission, outpatients' visits had to be limited only to those considered "urgent" according to the priorities code of the Italian health system (i.e. requiring medical assistance within 72 h or 10 days). In our opinion, these strict "urgency criteria" do not perfectly fit all IBD patients especially in the light of recent medical strategies such as early intervention, treat-to target and tight monitoring approaches (10) . According to this point of view, many "non urgent" interventions have been considered not deferrable and were regularly done. For example, patients in clinical remission ("non urgent" by definition) but requiring prompt evaluation and tight follow-up for planning long-term strategies have been regularly evaluated in a face-toface setting. Secondly, we have implemented virtual follow-up using phone calls with a tailored approach. In fact, the decision of postponing follow up visits or endoscopic procedures was made on strict case by case criteria, after evaluation of symptoms, laboratory tests and adherence to treatment and taking into account the general course of the disease in individual patients. This approach allowed us to reschedule all procedures (visits or endoscopies) only in low-risk patients without negative impact on IBD-related outcomes. To our knowledge this is the first experience exploring the impact of restructuring an IBD unit during pandemic on IBD-related outcomes in the post lockdown period.

Fabiola De Biasio: none Annalisa Aratari: None Stefano Festa has received consultancy fees and/or educational grants from Takeda, Sofar, Janssen Cilag Abbvie, Zambon.

Roberto Lorenzetti: none Claudio Papi has received consultancy fees and/or educational grants from Abbvie, MSD, Takeda, Pfizer, Janssen-Cilag, Chiesi, Sofar, Ferring and Zambon. No other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. 

Impact of the COVID-19 pandemic on Gastroenterology Divisions in Italy: A national survey

Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care

Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy

The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction

Place and causes of acute cardiovascular mortality during the COVID-19 pandemic

Impacts of the Coronavirus 2019 Pandemic on Gastrointestinal Endoscopy Volume and Diagnosis of Gastric and Colorectal Cancers: A Population-Based Study

Impact of the Coronavirus Disease 2019 Pandemic on Gastrointestinal Procedures and Cancers in the United States: A Multicenter Research Network Study

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality

The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When "non-urgent" does not mean "deferrable

Number of IBD follow up visits performed month by month in 2020 (black) and in 2019 (grey). B. Number of elective endoscopic procedures performed in IBD patients in March